RAPP EDWARD J — SEC insider filings

SEC reporting owner CIK 1171780. 58 insider filings on record with FilingPulse; latest filed 2026-10-13.

Transaction summary — filings shown

Covers the 50 most recent of 58 filings on record, filed 2021-11-15 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Xos, Inc. (XOS)Director252 legs · 400,000 sh · $633,820—27
AbbVie Inc. (ABBV)Director25——25

Insider filings — RAPP EDWARD J

FiledFormIssuerReported transactionsSource
2026-10-134Xos, Inc. (XOS)Grant/award (A): 1,814 @ $0EDGAR
2026-10-024AbbVie Inc. (ABBV)Grant/award (A): 129 (derivative) @ $261.59EDGAR
2026-07-144Xos, Inc. (XOS)Grant/award (A): 2,670 @ $0 · Grant/award (A): 60,584 @ $0EDGAR
2026-07-024AbbVie Inc. (ABBV)Grant/award (A): 134 (derivative) @ $251.64EDGAR
2026-05-124AbbVie Inc. (ABBV)Grant/award (A): 1,118 @ $0EDGAR
2026-04-144Xos, Inc. (XOS)Grant/award (A): 5,182 @ $0EDGAR
2026-04-024AbbVie Inc. (ABBV)Grant/award (A): 155 (derivative) @ $217.49EDGAR
2026-01-134Xos, Inc. (XOS)Grant/award (A): 2,401 @ $0EDGAR
2026-01-054AbbVie Inc. (ABBV)Grant/award (A): 147 (derivative) @ $228.49EDGAR
2025-10-144Xos, Inc. (XOS)Grant/award (A): 1,883 @ $0EDGAR
2025-10-024AbbVie Inc. (ABBV)Grant/award (A): 145 (derivative) @ $231.54EDGAR
2025-07-144Xos, Inc. (XOS)Grant/award (A): 62,377 @ $0 · Grant/award (A): 1,601 @ $0EDGAR
2025-07-024AbbVie Inc. (ABBV)Grant/award (A): 177 (derivative) @ $185.62EDGAR
2025-05-134AbbVie Inc. (ABBV)Grant/award (A): 1,203 @ $0EDGAR
2025-04-304Xos, Inc. (XOS)Grant/award (A): 1,407 @ $0EDGAR
2025-04-024AbbVie Inc. (ABBV)Grant/award (A): 155 (derivative) @ $209.52EDGAR
2025-02-264/AXos, Inc. (XOS)Grant/award (A): 1,475 @ $0EDGAR
2025-01-144Xos, Inc. (XOS)Grant/award (A): 1,065 @ $0EDGAR
2025-01-034AbbVie Inc. (ABBV)Grant/award (A): 182 (derivative) @ $177.70EDGAR
2024-12-174Xos, Inc. (XOS)Grant/award (A): 1,065 @ $0EDGAR
2024-10-024AbbVie Inc. (ABBV)Grant/award (A): 164 (derivative) @ $197.48EDGAR
2024-07-124Xos, Inc. (XOS)Grant/award (A): 28,694 @ $0 · Grant/award (A): 717 @ $0EDGAR
2024-07-024AbbVie Inc. (ABBV)Grant/award (A): 225 (derivative) @ $171.52EDGAR
2024-05-074AbbVie Inc. (ABBV)Grant/award (A): 1,322 @ $0EDGAR
2024-04-124Xos, Inc. (XOS)Grant/award (A): 445 @ $0EDGAR
2024-04-024AbbVie Inc. (ABBV)Grant/award (A): 212 (derivative) @ $182.10EDGAR
2024-01-174Xos, Inc. (XOS)Grant/award (A): 650 @ $0EDGAR
2024-01-034AbbVie Inc. (ABBV)Grant/award (A): 250 (derivative) @ $154.97EDGAR
2023-10-124Xos, Inc. (XOS)Grant/award (A): 15,151 @ $0EDGAR
2023-10-034AbbVie Inc. (ABBV)Grant/award (A): 259 (derivative) @ $149.06EDGAR
2023-07-134Xos, Inc. (XOS)Grant/award (A): 15,151 @ $0EDGAR
2023-07-054AbbVie Inc. (ABBV)Grant/award (A): 287 (derivative) @ $134.73EDGAR
2023-06-144Xos, Inc. (XOS)Grant/award (A): 444,444 @ $0EDGAR
2023-05-094AbbVie Inc. (ABBV)Grant/award (A): 1,450 @ $0EDGAR
2023-04-044AbbVie Inc. (ABBV)Grant/award (A): 243 (derivative) @ $159.37EDGAR
2023-04-044Xos, Inc. (XOS)Grant/award (A): 7,936 @ $0EDGAR
2023-01-124Xos, Inc. (XOS)Grant/award (A): 7,936 @ $0EDGAR
2023-01-034AbbVie Inc. (ABBV)Grant/award (A): 239 (derivative) @ $161.61EDGAR
2022-12-024Xos, Inc. (XOS)Purchase (P): 300,000 @ $0.69EDGAR
2022-10-044AbbVie Inc. (ABBV)Grant/award (A): 288 (derivative) @ $134.21EDGAR
2022-10-044Xos, Inc. (XOS)Grant/award (A): 3,378 @ $0EDGAR
2022-09-144Xos, Inc. (XOS)Grant/award (A): 115,606 @ $0EDGAR
2022-08-054Xos, Inc. (XOS)Grant/award (A): 3,816 @ $0EDGAR
2022-07-054AbbVie Inc. (ABBV)Grant/award (A): 237 (derivative) @ $153.16EDGAR
2022-05-094AbbVie Inc. (ABBV)Grant/award (A): 1,421 @ $0EDGAR
2022-04-044AbbVie Inc. (ABBV)Grant/award (A): 217 (derivative) @ $162.11EDGAR
2022-01-044Xos, Inc. (XOS)Grant/award (A): 1,474 @ $0EDGAR
2022-01-044AbbVie Inc. (ABBV)Grant/award (A): 260 (derivative) @ $135.40EDGAR
2021-11-224Xos, Inc. (XOS)Purchase (P): 100,000 @ $4.27EDGAR
2021-11-154Xos, Inc. (XOS)Grant/award (A): 57,229 (derivative) · Grant/award (A): 31,794 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1171780 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs